AAPL   381.91 (-0.46%)
MSFT   207.07 (-3.09%)
GOOGL   1,512.23 (-1.74%)
AMZN   3,104.00 (-3.00%)
NVDA   402.09 (-4.07%)
BABA   251.67 (-3.58%)
GE   6.70 (+0.15%)
TSLA   1,497.06 (-3.08%)
AMD   53.59 (-4.10%)
T   29.76 (-1.23%)
ACB   12.08 (+0.50%)
GILD   76.68 (+0.47%)
DIS   116.22 (-2.61%)
NFLX   525.50 (-4.23%)
BAC   24.19 (+0.71%)
BA   175.65 (-1.56%)
AAPL   381.91 (-0.46%)
MSFT   207.07 (-3.09%)
GOOGL   1,512.23 (-1.74%)
AMZN   3,104.00 (-3.00%)
NVDA   402.09 (-4.07%)
BABA   251.67 (-3.58%)
GE   6.70 (+0.15%)
TSLA   1,497.06 (-3.08%)
AMD   53.59 (-4.10%)
T   29.76 (-1.23%)
ACB   12.08 (+0.50%)
GILD   76.68 (+0.47%)
DIS   116.22 (-2.61%)
NFLX   525.50 (-4.23%)
BAC   24.19 (+0.71%)
BA   175.65 (-1.56%)
AAPL   381.91 (-0.46%)
MSFT   207.07 (-3.09%)
GOOGL   1,512.23 (-1.74%)
AMZN   3,104.00 (-3.00%)
NVDA   402.09 (-4.07%)
BABA   251.67 (-3.58%)
GE   6.70 (+0.15%)
TSLA   1,497.06 (-3.08%)
AMD   53.59 (-4.10%)
T   29.76 (-1.23%)
ACB   12.08 (+0.50%)
GILD   76.68 (+0.47%)
DIS   116.22 (-2.61%)
NFLX   525.50 (-4.23%)
BAC   24.19 (+0.71%)
BA   175.65 (-1.56%)
AAPL   381.91 (-0.46%)
MSFT   207.07 (-3.09%)
GOOGL   1,512.23 (-1.74%)
AMZN   3,104.00 (-3.00%)
NVDA   402.09 (-4.07%)
BABA   251.67 (-3.58%)
GE   6.70 (+0.15%)
TSLA   1,497.06 (-3.08%)
AMD   53.59 (-4.10%)
T   29.76 (-1.23%)
ACB   12.08 (+0.50%)
GILD   76.68 (+0.47%)
DIS   116.22 (-2.61%)
NFLX   525.50 (-4.23%)
BAC   24.19 (+0.71%)
BA   175.65 (-1.56%)
Log in

CVE:IPAImmunoprecise Antibodies Stock Price, Forecast & News

C$1.38
-0.10 (-6.76 %)
(As of 07/13/2020 04:00 PM ET)
Add
Compare
Today's Range
C$1.36
Now: C$1.38
C$1.60
50-Day Range
C$1.17
MA: C$1.59
C$1.94
52-Week Range
C$0.45
Now: C$1.38
C$2.06
Volume406,607 shs
Average Volume252,372 shs
Market CapitalizationC$96.47 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
ImmunoPrecise Antibodies Ltd. engages in the antibody production and related services in the United States, Canada, and Europe. It also provides human antibody development, hybridoma development, genetic immunization, rabbit monoclonal antibody development, recombinant protein expression and production, cryostorage, hybridoma sequencing, antibody generation, antibody purification, polyclonal development, and peptide production services. The company has a collaboration agreement with TetraGenetics, Inc. The company was founded in 1989 and is based in Victoria, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 1.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.51 out of 5 stars


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-604-8060626

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$12.55 million
Cash FlowC$0.03 per share
Book ValueC$0.21 per share

Profitability

Miscellaneous

EmployeesN/A
Market CapC$96.47 million
Next Earnings Date8/26/2020 (Estimated)
OptionableNot Optionable

Receive IPA News and Ratings via Email

Sign-up to receive the latest news and ratings for IPA and its competitors with MarketBeat's FREE daily newsletter.

Immunoprecise Antibodies (CVE:IPA) Frequently Asked Questions

How has Immunoprecise Antibodies' stock been impacted by COVID-19 (Coronavirus)?

Immunoprecise Antibodies' stock was trading at C$0.73 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, IPA shares have increased by 89.0% and is now trading at C$1.38. View which stocks have been most impacted by Coronavirus.

When is Immunoprecise Antibodies' next earnings date?

Immunoprecise Antibodies is scheduled to release its next quarterly earnings announcement on Wednesday, August 26th 2020. View our earnings forecast for Immunoprecise Antibodies.

Has Immunoprecise Antibodies been receiving favorable news coverage?

News stories about IPA stock have trended very negative this week, according to InfoTrie Sentiment. InfoTrie ranks the sentiment of news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Immunoprecise Antibodies earned a media sentiment score of -3.2 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View the latest news about Immunoprecise Antibodies.

Who are some of Immunoprecise Antibodies' key competitors?

What other stocks do shareholders of Immunoprecise Antibodies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Immunoprecise Antibodies investors own include Northwest Pipe (NWPX), ProntoForms (PFM), Algonquin Power & Utilities (AQN), Allstate (ALL), Albemarle (ALB), Altagas (ALA), AGNC Investment (AGNC), Advanced Energy Industries (AEIS), Automatic Data Processing (ADP) and Adaptimmune Therapeutics (ADAP).

Who are Immunoprecise Antibodies' key executives?

Immunoprecise Antibodies' management team includes the following people:
  • Dr. James S. Kuo M.B.A., M.D., Chairman (Age 54)
  • Dr. Jennifer Bath, Pres, CEO & Director
  • Mr. Robert Beecroft, Founder & Director
  • Mr. Charles Wheelock, Global Chief Technology Officer
  • Ms. Lisa Helbling, Chief Financial Officer

What is Immunoprecise Antibodies' stock symbol?

Immunoprecise Antibodies trades on the Canadian Venture Exchange (CVE) under the ticker symbol "IPA."

How do I buy shares of Immunoprecise Antibodies?

Shares of IPA and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Immunoprecise Antibodies' stock price today?

One share of IPA stock can currently be purchased for approximately C$1.38.

How big of a company is Immunoprecise Antibodies?

Immunoprecise Antibodies has a market capitalization of C$96.47 million and generates C$12.55 million in revenue each year.

What is Immunoprecise Antibodies' official website?

The official website for Immunoprecise Antibodies is immunoprecise.com.

How can I contact Immunoprecise Antibodies?

Immunoprecise Antibodies' mailing address is 880-580 Hornby St, VANCOUVER, BC V6C 3B6, Canada. The company can be reached via phone at +1-604-8060626.

This page was last updated on 7/13/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.